PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Predict and follow thanks to imaging the response to neoadjuvant chemotherapy in locally
advanced breast carcinoma. Hypothesis : FLT-(18F)PET will be a predictor superior to both
FDG-(18F) PET and MRI